机构:[1]Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China[2]School of Pharmacy, Macau University of Science and Technology, Macau, China[3]School of Life & Medical Sciences, University College London, London, UK[4]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China[5]KingMed Virology Diagnostic & Translational Center, Guangzhou, China[6]Guangdong-Hong Kong-Macao Joint Laboratory of Infectious Respiratory Disease, Guangzhou, China[7]Faculty of Medicine, Macau University of Science and Technology, Macau, China
Faculty Research Grant from Macau University of Science and Technology (Project code: FRG-20-001), the granted project of Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery from the Macao Science and Technology Development Fund (Project code: 0033/2019/AFJ; 001/2020/ALC), and Foshan Medicine Dengfeng Project of China (2019-2021).
语种:
外文
PubmedID:
中科院(CAS)分区:
出版当年[2020]版:
大类|2 区医学
小类|2 区药学
最新[2025]版:
大类|2 区医学
小类|1 区药学
第一作者:
第一作者机构:[1]Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China[2]School of Pharmacy, Macau University of Science and Technology, Macau, China
共同第一作者:
通讯作者:
通讯机构:[1]Dr. Neher’s Biophysics Laboratory for Innovative Drug Discovery, State Key Laboratory of Quality Research in Chinese Medicine, Macau University of Science and Technology, Macau, China[4]State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, Guangzhou Institute of Respiratory Health, the First Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University, Guangzhou, China[5]KingMed Virology Diagnostic & Translational Center, Guangzhou, China[6]Guangdong-Hong Kong-Macao Joint Laboratory of Infectious Respiratory Disease, Guangzhou, China[7]Faculty of Medicine, Macau University of Science and Technology, Macau, China[*1]State Key Laboratory of Quality Research in Chinese Medicine and Faculty of Medicine, Macau University of Science and Technology, Avenida Wai Long, Taipa, Macau, China
推荐引用方式(GB/T 7714):
Zhang Dingqi,Hamdoun Sami,Chen Ruihong,et al.Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.[J].Pharmacological research.2021,172:105820.doi:10.1016/j.phrs.2021.105820.
APA:
Zhang Dingqi,Hamdoun Sami,Chen Ruihong,Yang Lijun,Ip Chi Kio...&Wong Vincent Kam Wai.(2021).Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry..Pharmacological research,172,
MLA:
Zhang Dingqi,et al."Identification of natural compounds as SARS-CoV-2 entry inhibitors by molecular docking-based virtual screening with bio-layer interferometry.".Pharmacological research 172.(2021):105820